In addition to standard STEMI/NSTEMI post care, follow-up care for patients with COVID-19 and cardiovascular complications should include periodic evaluation every 1 to 3 months with detailed ...

"The FAMOUS-NSTEMI trial is unique since it is the first multicentre, randomised, controlled trial to assess FFR-guided management specifically in patients with recent heart attack, and in whom ...

Dr Amal Mattu breaks down the key updates — and lingering pitfalls — in the 2025 ACS guidelines that every acute care clinician should know.

Aspirin is still the first line of therapy for patients with unstable angina or non-ST-elevation myocardial infarction (NSTEMI), and ticagrelor can be used in place of clopidogrel or prasugrel ...

Multiparametric CMR performed before invasive coronary angiography in a patient with suspected NSTEMI. Using cardiac magnetic resonance (CMR) imaging to triage patients with suspected NSTEMI who are ...

What's New Since 2002? The primary objective in selecting a treatment strategy in UA/NSTEMI is to choose an approach likely to yield the best long-term clinical outcome. Two treatment pathways ...

An analysis of NSTEMI patients who undergo coronary revascularization within 24 hours of hospitalization showed an increased reduction in mortality, marking the first time this difference has been ...

For the group as a whole, QoL benefits of invasive management were greatest early on and tended to decline over the course of the year. In sensitivity analyses, measures of angina-specific QoL, angina ...